Medical Cash And Cash Equivalents Changes vs Net Income Analysis

MPW Stock  USD 4.04  0.01  0.25%   
Medical Properties financial indicator trend analysis is infinitely more than just investigating Medical Properties Trust recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medical Properties Trust is a good investment. Please check the relationship between Medical Properties Cash And Cash Equivalents Changes and its Net Income accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Properties Trust. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Cash And Cash Equivalents Changes vs Net Income

JavaScript chart by amCharts 3.21.15201420162018202020222024-1B-900M-800M-700M-600M-500M-400M-300M-200M-100M0100M200M300M400M500M600M700M -600M-500M-400M-300M-200M-100M0100M200M300M400M500M600M700M800M900M1B1.1B
JavaScript chart by amCharts 3.21.15Cash And Cash Equivalents Changestotal: -144.2MNet Incometotal: 3.1B

Cash And Cash Equivalents Changes vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medical Properties Trust Cash And Cash Equivalents Changes account and Net Income. At this time, the significance of the direction appears to have very week relationship.
Cash And Cash Equivalents ChangesNet IncomeDiversified AwayCash And Cash Equivalents ChangesNet IncomeDiversified Away100%
The correlation between Medical Properties' Cash And Cash Equivalents Changes and Net Income is 0.23. Overlapping area represents the amount of variation of Cash And Cash Equivalents Changes that can explain the historical movement of Net Income in the same time period over historical financial statements of Medical Properties Trust, assuming nothing else is changed. The correlation between historical values of Medical Properties' Cash And Cash Equivalents Changes and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Cash Equivalents Changes of Medical Properties Trust are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Cash And Cash Equivalents Changes i.e., Medical Properties' Cash And Cash Equivalents Changes and Net Income go up and down completely randomly.

Correlation Coefficient

0.23
Relationship DirectionPositive 
Relationship StrengthVery Weak

Cash And Cash Equivalents Changes

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Medical Properties Trust financial statement analysis. It represents the amount of money remaining after all of Medical Properties Trust operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most indicators from Medical Properties' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medical Properties Trust current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Properties Trust. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
At this time, Medical Properties' Selling General Administrative is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to climb to 21.16 in 2024, despite the fact that Tax Provision is likely to grow to (113.4 M).
 2021 2022 2023 2024 (projected)
Gross Profit1.5B1.5B830.2M537.8M
Total Revenue1.5B1.5B871.8M549.6M

Medical Properties fundamental ratios Correlations

0.630.430.431.00.980.990.990.660.350.99-0.151.00.070.990.420.820.980.990.991.00.320.87-0.10.710.37
0.630.150.30.620.560.580.640.470.390.630.10.62-0.130.610.160.630.580.60.610.62-0.050.6-0.190.53-0.02
0.430.150.270.380.480.350.50.19-0.080.290.40.410.280.411.00.420.430.410.410.460.220.72-0.030.030.23
0.430.30.270.420.410.40.430.79-0.110.40.140.430.320.460.260.570.370.420.460.420.140.51-0.20.080.15
1.00.620.380.420.970.990.980.680.340.99-0.191.00.070.990.360.820.970.990.990.990.30.85-0.110.730.36
0.980.560.480.410.970.960.990.610.30.96-0.190.980.110.970.460.750.990.990.970.990.40.85-0.010.710.46
0.990.580.350.40.990.960.970.690.360.99-0.170.990.060.990.330.830.950.970.990.970.310.84-0.180.690.36
0.990.640.50.430.980.990.970.630.360.96-0.080.990.050.980.490.810.980.980.980.990.310.89-0.090.670.36
0.660.470.190.790.680.610.690.630.010.660.040.660.310.710.170.860.570.630.710.620.350.69-0.520.240.34
0.350.39-0.08-0.110.340.30.360.360.010.410.30.39-0.910.37-0.080.290.270.330.370.320.070.15-0.260.080.07
0.990.630.290.40.990.960.990.960.660.41-0.220.990.00.990.270.80.960.980.990.970.290.8-0.120.740.35
-0.150.10.40.14-0.19-0.19-0.17-0.080.040.3-0.22-0.13-0.37-0.090.420.24-0.28-0.21-0.1-0.18-0.170.18-0.63-0.69-0.22
1.00.620.410.431.00.980.990.990.660.390.99-0.130.020.990.390.820.970.990.990.990.320.86-0.130.690.38
0.07-0.130.280.320.070.110.060.050.31-0.910.0-0.370.020.050.280.080.140.080.050.090.080.240.190.20.11
0.990.610.410.460.990.970.990.980.710.370.99-0.090.990.050.40.860.950.971.00.980.320.88-0.20.640.36
0.420.161.00.260.360.460.330.490.17-0.080.270.420.390.280.40.410.420.390.40.440.160.72-0.030.030.17
0.820.630.420.570.820.750.830.810.860.290.80.240.820.080.860.410.70.750.860.780.250.9-0.60.280.23
0.980.580.430.370.970.990.950.980.570.270.96-0.280.970.140.950.420.70.990.950.990.360.820.080.790.42
0.990.60.410.420.990.990.970.980.630.330.98-0.210.990.080.970.390.750.990.970.990.370.83-0.020.740.43
0.990.610.410.460.990.970.990.980.710.370.99-0.10.990.051.00.40.860.950.970.980.310.88-0.20.650.36
1.00.620.460.420.990.990.970.990.620.320.97-0.180.990.090.980.440.780.990.990.980.330.86-0.030.730.38
0.32-0.050.220.140.30.40.310.310.350.070.29-0.170.320.080.320.160.250.360.370.310.330.24-0.020.120.95
0.870.60.720.510.850.850.840.890.690.150.80.180.860.240.880.720.90.820.830.880.860.24-0.30.430.26
-0.1-0.19-0.03-0.2-0.11-0.01-0.18-0.09-0.52-0.26-0.12-0.63-0.130.19-0.2-0.03-0.60.08-0.02-0.2-0.03-0.02-0.30.460.02
0.710.530.030.080.730.710.690.670.240.080.74-0.690.690.20.640.030.280.790.740.650.730.120.430.460.2
0.37-0.020.230.150.360.460.360.360.340.070.35-0.220.380.110.360.170.230.420.430.360.380.950.260.020.2
Click cells to compare fundamentals

Medical Properties Account Relationship Matchups

Medical Properties fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets14.5B16.8B20.5B19.7B18.3B19.2B
Accounts Payable(107.9M)387.5M603.6M621.3M412.2M432.8M
Cash1.5B549.9M459.2M235.7M250.0M258.7M
Other Assets1.5B15.0B3.9B632.6M1.3B1.5B
Total Liab7.4B9.5B12.1B11.1B10.7B11.2B
Common Stock371K518K541K597K599K629.0K
Short Long Term Debt Total7.1B9.0B12.9B11.3B10.2B10.7B
Total Stockholder Equity7.0B7.3B8.4B8.6B7.6B8.0B
Other Liab45.7M180.9M183.6M70.3M80.9M61.7M
Net Debt5.7B8.5B11.0B11.1B9.9B10.4B
Retained Earnings83.0M(71.4M)(87.7M)116.3M(971.8M)(923.2M)
Non Current Assets Total12.1B14.9B17.9B18.2B15.7B16.4B
Non Currrent Assets Other10.5B12.5B15.3B(32.1B)11.4B11.9B
Long Term Debt7.0B8.9B11.3B10.3B8.5B9.0B
Cash And Short Term Investments1.5B549.9M459.2M235.7M250.0M271.7M
Net Receivables910.4M1.4B2.1B1.2B681.0M424.2M
Common Stock Total Equity371K518K541K597K686.6K720.9K
Common Stock Shares Outstanding428.3M530.5M590.1M598.8M598.5M628.4M
Liabilities And Stockholders Equity14.5B16.8B20.5B19.7B18.3B19.2B
Non Current Liabilities Total7.1B9.0B11.4B10.4B8.7B9.1B
Other Stockholder Equity7.0B7.5B8.7B8.5B8.6B9.0B
Total Current Assets2.4B1.9B2.6B1.4B1.4B1.3B
Accumulated Other Comprehensive Income(62.9M)(51.3M)(36.7M)(59.2M)42.5M44.6M
Other Current Liab291.5M(114.1M)(1.6B)(483.3M)1.1B1.1B
Total Current Liabilities307.6M474.9M633.4M649.1M2.0B2.1B
Current Deferred Revenue16.1M36.2M25.6M27.7M38.0M36.1M
Other Current Assets(1.8B)(1.1B)(1.2B)304.5M442.1M420.0M
Short Term Debt107.9M165.4M1.6B483.3M463.1M534.4M
Intangible Assets622.1M1.3B1.4B1.4B1.0B983.1M
Inventory1.8B1.01.2B(304.5M)(149.5M)(142.0M)
Net Tangible Assets6.4B6.0B8.4B7.2B8.3B4.3B
Noncontrolling Interest In Consolidated Entity107K5.3M5.5M1.6M1.4M1.3M
Retained Earnings Total Equity83.0M(71.4M)(87.7M)116.3M104.7M109.9M
Long Term Debt Total7.0B8.9B11.3B10.3B11.8B12.4B
Capital Surpluse7.0B7.5B8.6B8.5B9.8B5.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Medical Stock Analysis

When running Medical Properties' price analysis, check to measure Medical Properties' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Properties is operating at the current time. Most of Medical Properties' value examination focuses on studying past and present price action to predict the probability of Medical Properties' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Properties' price. Additionally, you may evaluate how the addition of Medical Properties to your portfolios can decrease your overall portfolio volatility.